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Abstract
Background: Embryo in vitro manipulations during early development are thought to increase
mortality by altering the epigenetic regulation of some imprinted genes. Using a bovine interspecies
model with a single nucleotide polymorphism, we assessed the imprinting status of the small
nuclear ribonucleoprotein polypeptide N (SNRPN) gene in bovine embryos produced by artificial
insemination (AI), in vitro culture (IVF) and somatic cell nuclear transfer (SCNT) and correlated
allelic expression with the DNA methylation patterns of a differentially methylated region (DMR)
located on the SNRPN promoter.
Results: In the AI group, SNRPN maternal expression is silenced at day 17 and 40 of development
and a third of the alleles analyzed are methylated in the DMR. In the IVF group, maternal transcripts
were identified at day 17 but methylation levels were similar to the AI group. However, day-40
fetuses in the IVF group showed significantly less methylation when compared to the AI group and
SNRPN expression was mostly paternal in all fetal tissues studied, except in placenta. Finally, the
SCNT group presented severe loss of DMR methylation in both day-17 embryos and 40 fetuses
and biallelic expression was observed in all stages and tissues analyzed.
Conclusion:  Together these results suggest that artificial reproductive techniques, such as
prolonged in vitro culture and SCNT, lead to abnormal reprogramming of imprinting of SNRPN
gene by altering methylation levels at this locus.
Background
The procedure of SCNT in mammals results in pregnancy
rates much lower than those obtained in vivo after insem-
ination and from transfer of embryos derived in vitro [1-
4]. Furthermore, cloned fetuses that survive to term often
have disorders such as oversized organs, increased or
decreased overall growth, respiratory failure and limb
malformations. In cattle and other ruminants, these
abnormal phenotypes are known as the large offspring
syndrome, or LOS [5,6]. Detailed examination of the extra
Published: 6 February 2009
BMC Developmental Biology 2009, 9:9 doi:10.1186/1471-213X-9-9
Received: 22 October 2008
Accepted: 6 February 2009
This article is available from: http://www.biomedcentral.com/1471-213X/9/9
© 2009 Suzuki et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Developmental Biology 2009, 9:9 http://www.biomedcentral.com/1471-213X/9/9
Page 2 of 13
(page number not for citation purposes)
embryonic membranes of SCNT pregnancies often high-
lights numerous placental abnormalities, including a
reduction in the number of cotyledons, and a decrease in
chorio-allantoic blood vessels. These observations are also
consistent with other reports where placentomes were
absent in the placenta in pregnancies that were lost
between days 30 and 60 of gestation [7,8]. Together, these
results suggest that improper development of the placenta
may play a major role in the fetal abnormalities and low
pregnancy rates in cattle SCNT. It has been suggested that
the pathological phenotypes in the placental and fetal
development of clones are associated with abnormal
reprogramming by the host ooplasm of the donor cell
used for nuclear transfer [9]. These abnormalities often
disturb the epigenetic regulation mechanisms inherited
from the differentiated donor cell, by altering the dynamic
nature of DNA methylation and chromatin modification
patterns during embryo development [10].
One of the most studied epigenetic modifications is DNA
methylation of cytosine residues within CpG dinucle-
otides; these are often associated with transcriptional
repression and implicated in maintaining genomic stabil-
ity, as well as silencing repetitive elements. DNA methyla-
tion is also implicated in the regulation of genomic
imprinting, genes that are exclusively expressed from only
one parental allele [10]. To date, only a few imprinted
genes have been characterized in cattle [11-15] and most
play essential roles in fetal development and placental
function. The bicistronic gene SNURF-SNRPN, referred
here as SNRPN, has been extensively studied in mice and
humans due to the correlation between disorders within
the SNRPN differentially methylated region (DMR) and
the pathogenesis of neurodevelopmental disorders
known as Prader-Willi Angelman syndrome. Interestingly,
decreased levels of the maternal allele methylation in the
SNRPN DMR has been observed in children conceived by
assisted reproductive technologies (ART), suggesting that
the SNRPN methylation pattern is affected by in vitro cul-
ture systems [16,17]. As demonstrated previously in cattle
[18], the SNRPN gene is also maternally imprinted in pre-
implantation bovine embryos, with a characterized DMR.
However, little is known about the effect of altered DNA
methylation patterns on allelic expression of the SNRPN
gene. A bovine interspecies model [Bos indicus (paternal
genome) × Bos taurus (maternal genome)] that is widely
used in warm climate animal breeding practices was
applied to assess genomic imprinting through parental-
specific polymorphisms [19,20]. Our objective here was
to characterize the imprinted status of SNRPN before (day
17) and after (day 40) implantation, to determine
whether the pattern of gene expression is associated with
DNA methylation levels, and finally to examine short and
mid term effects of in vitro culture on imprinting status of
SNRPN gene in embryos produced by IVF and SCNT.
In this study, we show that SNRPN is maternally
imprinted in pre- and post-implantation in vivo develop-
ment. Moreover, in vitro culture and somatic cell cloning
lead to decreased methylation of the DMR and conse-
quently biallelic expression of the SNRPN gene.
Results
Development during early gestation
Table 1 shows the results of blastocyst development, day-
17 and day-40 recoveries for all experimental groups. To
obtain samples that were not exposed to in vitro culture
conditions (control groups), we artificially inseminated
(AI) a superovulated heifer to harvest 3 intact elongated-
stage embryos at 17 d after insemination (only whole
embryos were used); 4 other heifers were inseminated to
recover day-40 in vivo fetuses (3) and their respective pla-
centas. The in vitro development of IVF and SCNT
embryos was assessed at day 8 of in vitro culture and
showed that development rate to the blastocyst stage was
similar for both groups. These results indicate that the
prolonged handling of the oocytes during SCNT was not
detrimental to the early stages of development in vitro, and
that the SCNT protocol used did not disturb early devel-
opment. To examine the development in vivo of in vitro-
derived SCNT and IVF blastocysts, during the first week
after transfer, groups of 10 blastocysts were transferred
non-surgically to synchronous recipients and recovered at
day 17 after estrus. Similar percentages of day-17 embryos
were collected from the SCNT and IVF groups (P > 0.05),
indicating that pre-implantation development was not
affected by cloning. Nonetheless, SCNT embryos were
smaller, e.g. less elongated, than their IVF counterparts,
Table 1: Survival rates of bovine oocytes subjected to AI, IVF and SCNT at pre- and postimplantation stages of development.
Embryos recovered from uterus
Group Blastocyst development to day 7.5 day 17* day 40*
AI - 3 3 (75%)**
IVF 27 (34%) 5 (50%) 3 (50%)
SCNT 26 (28%) 6 (45%) 3 (30%)
* percentage of embryos were calculated from the total number of transferred embryos.
** percentage of pregnancy was calculated from the total number of AI.BMC Developmental Biology 2009, 9:9 http://www.biomedcentral.com/1471-213X/9/9
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indicating that the proliferation of the trophoblasts was
somewhat retarded in this group. To obtain day-40 fetuses
in the IVF and SCNT groups, 1–2 embryos were trans-
ferred per recipient and viability was checked the day
before slaughter. As expected survival rates at day 40 were
slightly higher in the IVF group than in the SCNT group,
indicating that cloned embryos are less able to sustain
development beyond implantation.
Identification of a polymorphism for allele-specific 
transcript analysis
DNA and RNA were extracted, purified and used as a tem-
plate for sequencing and searching for single nucleotide
polymorphisms (SNP) between the Bos taurus and  Bos
indicus subspecies. In comparison to the Bos taurus pub-
lished sequence (GeneBank: AF101040), we detected an
adenine (A) to guanine (G) transition in Bos indicus DNA
located in exon 2 (position 151) of the SNURF-SNRPN
upstream reading frame protein [21], the 71 amino acid
protein SNURF that encompasses exons 1–3 (Figure 1).
Interestingly, this Bos indicus-specific missence mutation
leads to the substitution of an asparagine to a serine in
codon 50, a position within a phosphorylation site for
casein kinase II (CK2). In contrast to the widespread con-
servation of SNURF, Bos taurus SNURF differed at this
position whereas our findings show that the Bos indicus
SNURF CK2 site is homologous to other mammals,
including humans [21]. Genomic DNA samples were
obtained from Bos taurus (maternal), Bos indicus (pater-
nal) and crossbred tissues (Bos indicus vs.  Bos taurus).
Whereas the G and A where consistently found in Bos indi-
cus and Bos taurus samples, an overlap of G/A nucleotides
was detected in the sequence chromatograms of F1
genomic DNA confirming the use of interspecies F1
crosses for allele-specific gene expression analysis.
Between 15 and 20 clones were selected and sequenced
for allele expression analysis of each sample.
Allelic expression profiles of SNRPN gene at day 17
In the AI group, expression of the SNRPN gene was exclu-
sively paternal (Figure 2), thus demonstrating the
imprinted status of SNRPN gene locus during this pre-
implantation stage of development. This result also dem-
onstrates that the in vivo control group showed the same
SNRPN imprinting status observed in mice and humans,
thus validating our bovine hybrid model. However, in the
Identification of an allele-specific single nucleotide polymorphism (SNP) on SNRPN exon 2 Figure 1
Identification of an allele-specific single nucleotide polymorphism (SNP) on SNRPN exon 2. Schematic represen-
tation of the bicistronic SNURF-SNRPN locus in Bos indicus and Bos taurus, depicting the progression from DNA to protein. 
Genomic: Numbered boxes represent exons respective to SNURF (black) and SNRPN (gray); hatched box represents the DMR 
analyzed. Primer positions and amplicon size for DMR and allele-specific cDNA are indicated above. mRNA: Single transcript 
with the SNURF (black) and SNRPN (gray) open reading frames. Bos taurus and Bos indicus cDNA sequences are aligned to indi-
cate the SNP (G to A transition; open box) at position +151 (GeneBank AF1010140). Protein: Amino acid alignment of SNURF 
protein is shown for Bos taurus, Bos indicus and compared to a consensus sequence. Differences from the consensus are indi-
cated in white boxes. The Bos indicus SNP leads to a change from an aspergine to a serine in the phosphorylation site for casein 
kinase II (CK2) (adapted from [19]).
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IVF group, bi-allelic expression was observed at day 17
(21% of maternal SNRPN expression), indicating that the
in vitro culture conditions employed to produce day-8
blastocysts altered the imprinted status of SNRPN. More-
over, average levels of maternal expression were higher in
SCNT than in IVF (34% vs. 21% P < 0.05) and individual
SCNT maternal expression ranged between 20% and 50%
(Table 2), significantly above the average IVF value. These
results indicate that the protocol of SCNT alters the
imprinted status of SNRPN beyond the effects of in vitro
culture at this early stage of development and that the lev-
els of allelic expression vary significantly between differ-
ent SCNT embryos.
Allelic expression profiles of SNRPN gene at day 40
Allele-specific transcript analysis was also performed at
day 40 of development in samples of liver, muscle, brain,
heart and placenta (Figure 3). All AI samples showed
mono-allelic expression, i.e. exclusively paternal tran-
scripts, except heart (3%) and placenta (7%), where low
levels of maternal expression were observed. We defined
samples having 10% or less expression from the normally
silent maternal allele as being "leaky" but not enough to
be considered bi-allelic, demonstrating that SNRPN
imprinting is maintained after implantation in cattle fetal
tissues and placenta. IVF embryonic tissues in general
showed mostly paternal expression of the SNRPN gene.
Leaky maternal expression was observed in the IVF group
in liver (5%) and muscle (5%). Interestingly, bi-allelic
expression was found in placenta (17%), suggesting that
imprinting was not properly reestablished after in vitro
culture, particularly in this tissue. In the SCNT group all
tissues showed bi-allelic expression and maternal expres-
sion levels were higher than 15%. Heart, liver and pla-
centa were the most affected, where more than 20% was
maternally expressed. Together, results of allelic expres-
sion indicate that the SNRPN gene is maternally
imprinted at pre-implantation stages and this status is
maintained throughout development until day 40 in all
embryonic tissues analyzed in our control group (AI).
However, the placenta seemed to be affected by in vitro
culture, since bi-allelic expression mode continued even
after implantation in the IVF group and, in SCNT
embryos, all tissues showed bi-allelic expression of
SNRPN.
Methylation analysis of the SNRPN DMR at day 17
Once imprinting status was characterized, we assessed the
methylation of the SNRPN DMR. Genomic DNA was
extracted and, after bisulfite reaction, the ratio of methyl-
ated CpG sites over the 39 CpG sites present in the DMR.
Previous studies had shown that, in day-17 preimplanta-
tion embryos, parent of origin methylation was repre-
sented by roughly 40 to 50% of methylated versus
unmethylated sites [18]. To validate the method used for
DNA methylation analysis, we mixed equal proportions
(50% of each) of bisulfite treated DNA extracted from ger-
minal vesicle (GV) oocytes (fully methylated CpG sites)
with sperm (unmethylated CpG sites). For all samples
analyzed, between 15 and 20 clones were selected and
sequenced for CpG content. Figure 4 shows representative
CpG methylation analysis at the SNRPN DMR obtained
from the bisulfite treatment. The percentage of paternal
alleles was approximately 38% in somatic cells and our
standard 1:1 control, indicating that our analysis repre-
sented an unbiased contribution from each parental
allele. These results were also consistent with the methyl-
ation levels found in previous studies [18].
Once the method of SNRPN DMR analysis was validated
we assessed the methylation levels in the day-17 AI con-
trol embryos. Individual patterns of methylation were
very similar to previous reports [18]. We confirmed that AI
day-17 embryos maintained differentiated methylation
patterns inherited from gametes, as roughly 40% of the
SNRPN DMR was methylated (Figure 5). Methylation
ratio in the IVF group was lower but not significantly dif-
ferent from the AI group (38% vs. 26%, P > 0.05; Figure
5), indicating that in vitro culture effects were only slightly
detrimental to methylation maintenance. In contrast,
severe loss of methylation was observed in the SCNT
group, where less than 2% of methylated sites were
observed. Similar results were found in clones produced
by traditional methods of SCNT using zona-intact enucle-
ation [18] confirming that the hand made cloning (HMC)
method for SCNT [22] results in a similar methylation
outcome. Interestingly, embryos with lower DMR methyl-
ation levels also showed higher levels of bi-allelic expres-
sion, particularly in the SCNT group (Table 2).
Table 2: Percentage of paternal expression of SNRPN gene and methylated CpGs islands on SNRPN DMR of AI, IVF and SCNT day-17 
embryos.
AI IVF SCNT
E m b r y o s 12312345 1 2 3 4 5 6
Paternal Expression 100 100 100 85 85 85 80 80 60 70 50 70 80 80
DMR Methylation 27.2 32.2 55.0 29.1 22.0 47.1 17.0 15.3 0.9 0.5 4.0 0.4 0.1 3.8BMC Developmental Biology 2009, 9:9 http://www.biomedcentral.com/1471-213X/9/9
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Methylation analysis of the SNRPN DMR at day 40
Similar methylation patterns to those seen in AI day-17
embryos were also observed in AI day-40 fetuses (Figure
6). Almost all tissues showed 40% of overall methylation,
supporting the hypothesis that parent of origin methyla-
tion is maintained throughout embryo development. Sur-
prisingly, heart samples showed very low levels of
methylation in all day-40 fetuses analyzed (Table 3) even
though gene expression was mostly mono-allelic in this
tissue. In the IVF group, significantly lower methylation
levels were found in all tissues particularly heart, where
methylation ratios were comparable to the AI control (Fig-
ure 7). As at day 17, SCNT day-40 embryos showed loss of
methylation levels in every fetal tissue and the placenta,
indicating that abnormal methylation levels were main-
tained throughout early gestation and suggesting that
methylation failures acquired during early stages persist
throughout development.
Association between SNRPN allelic expression and the 
DMR methylation
Interestingly, when results from allelic expression and
methylation ratio were combined, particular patterns
were observed in different tissues (Table 3). In an attempt
to correlate methylation patterns with expression, a bivar-
iate analysis was performed on data from day-17 embryos
and from each tissue from day-40 fetuses (Figure 8). A
highly significant positive correlation was found between
expression and methylation in day-17 embryos (P <
0.01), and brain of day-40 fetuses (P < 0.01). Day-40 liver,
muscle and heart also showed a significant but less tight
correlation between expression and DMR methylation (P
< 0.05). Interestingly, placenta tissues showed the lowest
correlation between expression and methylation patterns
(R2 = 0.3; P > 0.1), supporting the notion that methylation
does not play a critical role in imprinting gene expression
in this tissue [23]. Together, these results suggests that in
general methylation of SNRPN DMR is positively associ-
ated with allelic expression, however the association
seems to be stronger in some tissues than others.
Discussion
The use of a Bos indicus/Bos taurus interspecies model ena-
bled us to provide additional information on imprinting
regulation of the SNRPN gene by analyzing simultane-
ously the methylation status and the allelic expression of
SNRPN gene during the transitional period between the
elongated pre-implantation embryo to the initial post-
implantation stage in embryonic and extra-embryonic tis-
sues in cattle. Furthermore, we characterized alterations to
the transcription patterns and DMR methylation of
SNRPN cause by exposing early stage embryos to in vitro
culture conditions and SCNT, demonstrating that ART can
significantly disturb the epigenetic control of imprinted
genes.
Imprinted gene profiles have been previously reported in
ruminants [11,13,14], and the interest in these genes
arises from their implication in embryo and fetal develop-
ment. In many clinical cases in humans or livestock ani-
mals, an association of abnormalities found in
pregnancies resulting from ART and abnormal expression
of imprinted genes is often found. A better knowledge of
imprinted genes could provide clues to understand and
improve in vitro culture conditions. Ultimately, in SCNT,
imprinting analysis is essential to define the mechanisms
underlying the ability of the oocyte to reprogram the epi-
genetic memory of somatic donor cells.
The maternally imprinted SNRPN gene has been exten-
sively studied in mice and humans [24] due to its associa-
tion to Angelman and Prader-Willi syndromes; it has now
also been putatively linked to ART and infertility [16].
Although ART has been extensively used in the bovine
species, little is known about SNRPN imprinting status.
Although we confirm previous findings that the DMR
methylation pattern in IVF embryos is not different from
the AI group [18], we have found bi-allelic SNRPN expres-
sion at day 17 in preimplantation IVF embryos subjected
to in vitro culture up to day 8. Recently, bi-allelic expres-
sion of SNRPN and a number of other imprinted genes
was found in day-8 bovine blastocysts, suggesting that
mono-allelic expression may not be required for most
Maternal expression analysis of SNRPN gene at day 17 Figure 2
Maternal expression analysis of SNRPN gene at day 
17. Average percentages of maternal expression in embryos 
produced by AI (n = 3), IVF (n = 5) and SCNT (n = 6). 
SNRPN reverse transcription-polymerase chain reaction 
fragments were cloned into a plasmid vector and sequenced 
for the parental SNP. Ratios were based on the total number 
of paternal alleles (G; Bos indicus SNP) found over the total 
number individual clones sequenced. *Subscripts represent 
significant differences within groups (P < 0.05).
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imprinted genes during preimplantation development
and occur in a gene- and time-dependent manner [25].
However, results from our AI control showed no sign of
bi-allelic expression, whereas the bi-allelic expression
found in day-17 IVF embryos was also observed at post-
implantation stages, suggesting that placenta tissues
might be more susceptible to the effects of in vitro embryo
culture. In our study, bi-allelic expression extended to
post-implantation development in day-40 placenta, and
since pre-implantantion embryos are mostly composed of
extraembryonic tissue, this indicates that imprinting was
already perturbed during earlier development. In the pla-
centa, imprinting is probably regulated by mechanisms
other than DNA methylation. In fact, studies in mice have
revealed that imprinting establishment of Xist gene does
not require the DNA maintenance methyltransferase
DNMT1 [21]. Instead, the process of X chromosome inac-
tivation is rather dependent on histone modifications
associated with transcriptional repression by histone H3
methylated at lysine 9 (H3K9me) and 27 (H3K27me) as
well as the Polycomb H3K27 methyltransferase complex,
which is involved in the maintenance of transcriptional
repression [21,24]. In support of these results we found
the lowest association between methylation and allelic
expression in placenta (Figure 8f). However, DMR meth-
ylation levels were diminished also in most embryonic tis-
sues and we do not exclude the possibility of further
complications due to loss of methylation. A wide range of
genes can be affected by in vitro embryo culture, as
reported for preimplantation mouse embryos [26]. None-
theless, these results provide support for the hypothesis
that placental tissue is more affected by in vitro culture
than embryonic tissues [6,26,27], and pregnancy abnor-
malities could relate to problems observed later during
gestation, when the placenta becomes more important to
fetal development.
SNRPN DMR in SCNT embryos and fetuses showed severe
loss of methylation and maternal expression of around
30% in day-17 embryos (Figure 2). Bi-allelic expression
also persisted in day-40 extra-embryonic and embryonic
tissues, although maternal expression was less pro-
Maternal expression analysis of SNRPN gene at day40 Figure 3
Maternal expression analysis of SNRPN gene at day40. Average percentages of maternal expression in tissues (placenta 
and fetus tissues: brain, heart, liver and muscle) obtained from embryos produced by AI (black bar) and IVF (open bars) and 
SCNT (gray bars). SNRPN reverse transcription-polymerase chain reaction fragments were cloned into a plasmid vector and 
sequenced for the parental SNP. Ratios were based on the total number of paternal alleles (G; Bos indicus SNP) found over the 
total number individual clones sequenced. a, b subscripts represent significant differences within tissues (P < 0.05).
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nounced than in day-17 embryos. It is likely, therefore,
that problems with pregnancies are initially due to defects
at the early stages of placenta development, which are
aggravated as the embryo develops further. In support of
this hypothesis, some underdeveloped blastocysts (less
elongated) were found at day 17 in SCNT but not in the
IVF group. However, at day 40 no pathologies were found
in SCNT embryonic tissues, e.g. their sizes were normal
and pregnancy progressed until collection, but their pla-
centa had no visible placentomes and limited signs of vas-
cularization of the choriallantoic membrane. Similar
observations have been previously reported in cross-spe-
cies clones by Dindot et al [7]. These results found in pre-
and post-implantation trophoblastic tissue raise the ques-
tion whether abnormal expression observed in embryonic
tissues is a consequence of donor cell reprogramming fail-
ures, or if placenta malfunction would eventually account
for abnormal expression of imprinted genes observed in
day-40 fetal tissues. Another possibility is that defects
caused by SCNT, other than those related to genomic
imprinting, affect cell fate choices in early development
and that cells with more anomalies (competence, cell
division, polyploidy) are preferentially incorporated into
the trophectoderm rather than the inner cell mass, as seen
in tetraploid complementation [28]. However, loss of
methylation in embryonic tissues seems to be associated
with reprogramming failures of the donor cell [29]. Stud-
ies indicate that the methylation of imprinted genes is
maintained throughout embryo development and deter-
mines either the repression or expression of these genes
while the rest of the genome becomes demethylated [10].
Probably failures in donor cell reprogramming and detri-
mental effects of in vitro culture could together account for
the severe abnormalities found in the placentas of SCNT.
To our knowledge, this is the first study to compare meth-
ylation directly with imprinting status in different tissues
during pre- and post-implantation stages of development.
More studies are needed to determine whether, in cattle,
there are other DMRs acting on the same locus, or if
another imprinting mechanisms, i.e. histone acetylation,
play a role as important as DNA methylation in the con-
trol of SNRPN expression.
Conclusion
Bi-allelic SNURF-SNRPN gene expression was found in
IVF and SCNT preimplantation embryos subjected to in
vitro culture, which persisted only in fetal tissues of cloned
cattle. Loss of methylation was also found in embryonic
and extra-embryonic tissues of pregnancies derived by IVF
embryos cultured in vitro. Furthermore, bi-allelic expres-
sion was observed, in placenta, but not fetal tissues. Thus,
we postulate that the detrimental effects of in vitro culture
on pre- and post-implantation, play an important role in
the establishment of SNRPN imprinting, particularly in
placenta tissues and, in SCNT, is aggravated by failures in
donor cell reprogramming.
Methods
All procedures were performed in compliance with the
Guide for the Care and Use of Agricultural Animals in
Research and Training, approved by the animal experi-
mentation committee of the Université de Montréal sanc-
tioned by the Canadian Council on Animal Care.
SNRPN DMR methylation in control samples Figure 4
SNRPN DMR methylation in control samples. DNA bisulfite analysis showing the CpG methylation patterns in the 
SNRPN DMR of (a) control fibroblast donor cell derived from a day-60 in vivo produced fetus and (b) a 1:1 mixture of paternal 
(unmethylated)/maternal (methylated) DNA recovered from sperm and oocytes, respectively. Each line represents an individ-
ual clone that was sequenced. Black filled circles represent methylated CpG islands, and open circles indicate unmethylated 
CpG sites.
a bBMC Developmental Biology 2009, 9:9 http://www.biomedcentral.com/1471-213X/9/9
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Nuclear donor cells
Fetal fibroblast cell cultures were established from a 60-
day-old crossbred fetus produced by AI of a Holstein (Bos
taurus) heifer with semen from a Nellore (Bos indicus) bull.
Fetal tissues (brain, heart, liver, muscle and placenta) were
minced manually and digested with 0.25% trypsin and
0.02% EDTA (Gibco BRL, Burlington, ON, Canada) at
37°C for 10 min. Isolated cells were washed and cultured
for approximately 4 d in Dulbecco modified Eagle
medium (DMEM; Gibco BRL) supplemented with 10%
fetal bovine serum (FBS; Gibco BRL) and 0.5% antibiotics
(penicillin 10000 U/ml and streptomycin 10 000 μg/ml;
Gibco BRL) at 37°C in 5% CO2. When the cultures were
confluent, primary passage cells were frozen in culture
media supplemented with 10% dimethyl sulfoxide and
stored in liquid nitrogen. Donor cells were thawed at
37°C for 1 min and cultured to confluence for a maxi-
mum of 5 passages before use as donor cells.
Host oocytes
Cattle ovaries were collected from a local abattoir and
transported to the laboratory in saline at 30–35°C within
approximately 2 h after slaughter. Follicles with diameters
between 2 and 10 mm were punctured with a 18-gauge
needle, and cumulus oocyte-complexes (COC) with
approximately 4 to 6 layers of cumulus cells and homoge-
neous oocyte cytoplasm were washed in Hepes-buffered
tissue culture medium (TCM-199; Gibco BRL) supple-
mented with 10% (vol/vol) FBS. Groups of 20 COC were
placed in 100 μl of bicarbonate-buffered TCM-199 sup-
plemented with 10% FBS, 50 μg/ml LH (Ayerst, London,
ON, Canada), 0.5 μg ml/ml FSH (Folltropin-V; Vetrep-
harm, St-Laurent, PQ, Canada), 1 μg ml/ml estradiol 17-β
(Sigma-Aldrich, St. Louis, MO), 22 μg ml/ml pyruvate
(Sigma-Aldrich), and 50 μg/ml gentamicin (Sigma-
Aldrich). After 19 to 20 h of in vitro maturation, cumulus
cells were removed from the COC by vortexing for 2 min
in PBS and 0.2% hyaluronidase (Sigma-Aldrich). Only
oocytes with homogeneous cytoplasm and intact cell
membrane were selected for micromanipulation.
In vivo and in vitro-derived embryos
Production of embryos and fetuses for in vivo and in vitro
controls, as well as donor cells were conducted as
described previously [18]. Briefly, in vivo-derived embryos
were obtained from Holstein heifers that were superovu-
lated by intramuscular injection of porcine FSH (Folltro-
pin-V) given every 12 h in decreasing doses starting with
60 mg at day 9, 50 mg at day 10, 30 mg at day 11 and
finally 20 mg at day 12 of the estrous cycle. At day 13 cows
received an injection of 500 μg of cloprostenol (Estru-
mate; Schering-Plough Animal Health, Pointe-Claire, QC,
SNRPN DNA methylation patterns at day 17 Figure 5
SNRPN DNA methylation patterns at day 17. Average 
percentage methylation levels of day-17 embryos derived 
from AI, IVF and SCNT. Bisulfite methylation data was 
obtained by computing the number of methylated CpG sites 
over the total number of CpG sites. *Subscripts represent 
significant differences within groups (P < 0.05).
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Table 3: Percentage of paternal expression of SNRPN gene and methylated CpGs islands on SNRPN DMR of AI, IVF and SCNT tissues 
of day-40 fetuses and placenta.
Paternal Expression (%) Methylation (%)
Groups fetuses liver muscle heart brain placenta liver muscle heart brain placenta
AI 1 100 100 90 100 100 25.3 35.2 8.1 33.7 31.6
2 100 100 100 100 80 33.0 33.2 7.6 30.2 34.7
3 100 100 100 100 100 29.7 27.5 8.4 39.6 30.6
IVF 1 90 90 100 90 100 3.5 10.3 3.8 21.1 20.4
2 95 95 100 80 70 14.3 9.8 8.8 8.1 14.5
3 100 100 100 100 80 20.9 15.4 10.6 26.5 20.6
SCNT 1 75 70 90 80 80 1.6 4.0 1.2 7.6 2.0
2 100 90 70 90 80 3.4 1.4 1.3 10.9 8.6
3 70 85 75 80 75 3.4 1.8 3.4 6.5 1.0BMC Developmental Biology 2009, 9:9 http://www.biomedcentral.com/1471-213X/9/9
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Canada) and were artificially inseminated (AI) in the next
48 h after cloprostenol injection.
In vitro-produced embryos were derived using standard
protocols of in vitro maturation (IVM), fertilization (IVF)
and culture (IVC) [12]. Briefly, bovine ovaries were
obtained from a local slaughterhouse and transported to
the laboratory within 4 h in saline at 32°C. For IVM,
groups of 20–25 COC were cultured in 100 μl drops of
Tyrode medium supplemented with 0.6% BSA (fraction V;
Sigma-Aldrich), lactate, pyruvate, gentamicin, and
heparin (10 μg/ml). For IVF, frozen-thawed spermatozoa
were washed and centrifuged through a Percoll (Sigma)
gradient and diluted to 106 live spermatozoa/ml. After 24
of IVM, COCs were added to fertilization drops and at 20
h following the start of incubation with spermatozoa,
oocytes were denuded of cumulus cells by brief shaking.
For IVC, putative IVF zygotes were transferred to 25 μl
drops of synthetic oviduct fluid (SOF medium) and cul-
tured for 8 d, with additional 25 μl of SOF medium. The
same IVC conditions were used for the oocytes recon-
structed by SCNT.
Nuclear transfer
The SCNT protocol used was a slight modification from a
previous report of hand made cloning (HMC) [22].
Oocytes were selected in groups of 100 and placed in 1.5
mg/ml pronase in TCM 199 supplemented with FBS 10%
for about 4 min. Zona-free oocytes were washed thor-
oughly in TCM supplemented with FBS 20% for 3 min
and cultured in 0.4 μg/ml demecolcine for at least 30 min.
Treated oocytes with a visible protruding membrane were
placed in medium supplemented with 5.0 μg/ml cytocha-
lasin and 10% FBS and manually bisected using a micro
blade on a stereomicroscope. After bisection, oocytes were
stained with 2 μg/ml Hoescht 33342 and checked for the
absence of chromatin using a short exposure to UV fluo-
rescence. Nuclear donor cells were thawed, washed and
SNRPN DMR methylation in day-40 tissues Figure 6
SNRPN DMR methylation in day-40 tissues. Representative samples of bisulfite methylation analysis of placenta (left col-
umn) and brain (right column) of AI (a, b) IVF (c, d) and SCNT (e, f) samples. Each line represents an individual clone that was 
sequenced. Black filled circles represent methylated CpG islands, and open circles indicate unmethylated CpG sites.
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placed in 50 μl of culture media (DMEM, supplemented
with 10% FBS and 0.5% antibiotics). Nuclear transfer was
performed using confluent cells that were maintained in
culture for 3–5 passages. Cytoplasts were placed individu-
ally in a 50 μl drop containing 500 μg/ml of phytohemag-
glutinin (Sigma) for about 3 sec and then quickly
positioned over a single donor cell placed at the bottom
of the dish. After attachment of the donor cell, the cyto-
plast-somatic cell couplets were placed in 0.3 M mannitol
solution containing 0.1 mM MgSO4 and 0.05 mM CaCl2
and exposed to a 1.2 kV electric pulse lasting 70 μsec. After
electrical stimulation, couplets were washed and cultured
individually in 10 μl drops of 6-dimethylaminopurine
(DMAP, Sigma-Aldrich) for 3 h. After DMAP treatment,
reconstructed oocytes were washed and cultured in 40 μl
drops of SOF modified medium supplemented with 0.8%
BSA-V fatty acid free (Sigma-Aldrich) under equilibrated
mineral oil at 39°C in a humidified atmosphere of 5%
CO2 and 5% O2. Embryos were cultured in groups of 4 per
drop in small individual wells (500 μm diameter) pre-
pared with a sterile needle to avoid separation of blast-
omeres during development. Reconstructed embryos were
cultured in vitro for a period of 8 d.
Day-17 elongating embryos and day-40 fetuses
The estrous cycle of Holstein heifers was synchronized by
an injection of 500 μg of the prostaglandin F2α analogue,
cloprostenol (Estrumate, Schering Canada Inc). Six to 8 d
after the standing heat, day-8 in vitro-produced or SCNT
blastocysts were transferred to the uterine horn ipsilater-
ally to the corpus luteum. Embryos were washed with
TCM-199 Hepes-buffered medium supplemented with
10% of FBS, loaded into a 250 μl straw and transferred to
recipient heifers. One group of heifers received between
10 to 15 day-8 IVF or SCNT embryos and allowed to
develop for another 9 d in the uterine horn. Day-17 elon-
gated embryos were non-surgically recovered by flushing
the uterus of the recipient heifers with PBS using a Foley
catheter. Embryos were removed from the flushing media
and inspected to select those that were recovered intact.
After selection, embryos were washed three times in PBS
and frozen individually at -70°C in 0.2 ml of distilled
water. Only those embryos that were recovered intact were
SNRPN DNA methylation patterns at day 40 Figure 7
SNRPN DNA methylation patterns at day 40. Average percentage methylation levels in tissues (placenta and fetus tis-
sues: brain, heart, liver and muscle) obtained from embryos produced by AI (black bars) and IVF (open bars) and SCNT (gray 
bars). Bisulfite methylation data was obtained by computing the number of methylated CpG sites over the total number of 
CpG sites. *Subscripts represent significant differences within groups (P < 0.05).
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used for the experiments. The second group of heifers was
allowed to continue gestation to day-40 after SCNT or IVF.
Recipients carrying fetuses with a normal heartbeat were
slaughtered at the local slaughterhouse and transported to
the laboratory on ice within approximately 1 h postmor-
tem. Samples from liver, muscle, heart, whole brain and
placenta (intercotiledonary allantoic membrane) were
collected from each viable gestation, snap-frozen in liquid
nitrogen and stored at -70°C until further analysis.
Bivariate analysis of SNRPN DMR methylation and paternal expression values Figure 8
Bivariate analysis of SNRPN DMR methylation and paternal expression values. a) day-17 embryos, b) day-40 liver, c) muscle, 
d) heart, e) brain and f) placenta. (.) IVF, (+) in vivo, (x) SCNT.
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Bisulfite sequencing
DNA was isolated from day-17 embryos and day-40 tis-
sues using Qiagen DNAeasy extraction kit, according to
the manufacture's instructions. Approximately 200 ng of
total genomic DNA was used for a bisulfite treatment reac-
tion using the EZ DNA methylation kit supplied by Zymo
Research®, according to the manufacturer's instructions.
Primers specific for bisulfite-converted DNA for SNRPN
were designed according to previous publication [18].
Nested PCR amplifications were necessary due to the lim-
ited amounts of DNA (approximately 200 ng) available
for analysis. Primers were designed according to bisulfite
standards (no CpG sites within primers and at least 2
cytosines within primer sequence to select for converted
sequences). For the outside nested PCR, the primer
sequences were as follows: Forward 5'GGAAAGTTTGAG-
GAAATTTGAATAAGG-3'; Reverse 5'-CAAATAC-
CCCCAAAACCTAACAAAAC-3'. The primers used for the
inside nested reaction were as follows: Forward 5'-
TTGGGAGGTATTATTTTGGGTTGAAG-3'; Reverse 5'-
AAAAAATCAATCCAACCCCAAACCTC-3'. Each 50 μl PCR
reaction contained 4 μl of bisulfite-treated DNA, 1 μl of
each primer (10 μM), 2.5 μl (100 μM) deoxynucleotide
triphosphates (Invitrogen), 5 μl 5× PCR buffer (300 mM
Tris-HCl, 7.5 mM ammonium sulfate, 12.5 mM MgCl2)
(Invitrogen), and 1.25 U of DNA Taq polymerase (Invit-
rogen). First-round PCR was performed under the follow-
ing conditions: 4 min at 94°C, 2 min at 55°C, and 2 min
at 72°C for two cycles, followed by 35 cycles of PCR con-
sisting of 1 min at 94°C, 2 min at 55°C, and 2 min at
72°C. For the second round of PCR, 4 μl of the first-round
sample were used, and the conditions for the PCR were
the same as the first-round conditions, except that the first
two cycles were omitted. Fragments were resolved in 1.2%
agarose gels, followed by purification using agarose puri-
fication kit from Qiagen. Purified fragments were sub-
cloned in pGEM T easy Vector (Promega), and cell
transfection protocol was performed using competent
Escherichia coli cells. Clones containing the appropriate
inserts were sequenced using an automated sequencer.
Since bisulfite converts all unmethylated cytosines,
whether or not they are in CpG dinucleotides, to
guanines, only sequences with greater than 95% bisulfite
conversion efficiency were used for analysis (i.e., to avoid
false overestimation of methylated CpGs). Nucleotides
mutations or any difference within the sequence (poly-
morphisms) between clones with similar CpG methyla-
tion profiles were verified to ensure that unique clones
were represented. We examined 39 CpG sites in a 548-bp
fragment of SNRPN. Absence of strain-specific single
nucleotide polymorphisms prevented the parental origin
of the sequenced strands from being determined.
Allele-specific polymorphism in cDNA
RNA was extracted using the RNAeasy Extraction kit (Qia-
gen) following manufacturer's instructions. Reverse tran-
scription and polymerase chain reaction (RT PCR) was
performed using Omniscript RT-PCR kit (Qiagen). cDNA
was used as a template for the next PCR using primers
SNRPN Forward (5'-GGAGATGCGTGACGTTGTGT) and
Reverse (5'-GGTGTTCCAATACTGCTTTAACC). A 50 μl
reaction was performed consisting of 5 μl 10× PCR buffer
(Promega), 4 μl 25 mM MgCl2, 1.25 μl 10 mM dNTPs, 2.5
μl 3 M forward primer, 2.5 ml 3 M reverse primer, 2 μl
DNA, and 1 ml Taq (Promega). PCR reactions were per-
formed for 35 cycles at 94°C (2 min), 94°C (30 sec),
65°C (30 sec), 72°C (35 sec), 72°C (3 min), and held at
10°C. Fragments were resolved on 1.2% agarose gels,
purified and subcloned in sequencing vectors pGEM T
easy Vector (Promega) and transformed in competent
Escherichia coli cells. Sequence analysis indicated the pres-
ence of a SNP between the Bos indicus and  Bos taurus
genomes. Plasmids were purified, according to Qiagen's
protocol, and results examined individually for the pres-
ence or absence of the paternally expressed Bos indicus
genome (guanine) or maternally expressed Bos taurus
genome (adenine). Results are expressed in percentages of
individual cloned sequences possessing the maternal (Bos
taurus) over the total number of clones analyzed.
Statistical analyses
Statistical analysis was performed using the Chi-square
test. For methylation analysis, data was analyzed by com-
puting frequency of methylated sites over the number of
unmethylated CpGs islands. For gene expression, data
was analyzed using Bioedit software aligning program and
frequency of paternal computed over maternal allele SNP.
For both cases the level of significance was set at P < 0.05.
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